Skip to main content
NewslettersWatchlist

Viking Thera(VKTX-Q)
NASDAQ

Today's Change
Real-Time Last Update Last Sale Cboe BZX Real-Time
Day Low50.53
Day High54.28
Open:51.30
Price movement based on the high, low and last over the given period.
Previous Close
52-Week High/Low
Volume
Average Volume
Price/Earnings (TTM)
Forward Annual Dividend & Yield
Market Capitalization, $M
5-Day Change
Realtime quote and/or trade prices are not sourced from all markets.
Select a category then submit the form to load news
Motley Fool
3 Things You Need to Know if You Buy Viking Therapeutics Today
Motley Fool
Is It Too Late to Buy Viking Therapeutics Stock?
Motley Fool
Prediction: Acquisitions Will Skyrocket Under The Trump Administration. Here's 1 Pharmaceutical Company I Have My Eyes On.
Motley Fool
Should You Forget Eli Lilly and Buy This Magnificent Biotech Stock Instead?
Motley Fool
Did Viking Therapeutics Just Say "Checkmate" To Eli Lilly?
Motley Fool
Is Viking Therapeutics a Buy on the Dip?
Motley Fool
4 Reasons Why Buying Viking Therapeutics Stock Right Now Is a Smart Move
Motley Fool
Got $5,000? Viking Therapeutics Stock Just Got a Big New Green Flag
Motley Fool
Is Viking Therepautics a Buy Now?
Motley Fool
Why Viking Therapeutics Stock Plummeted After Soaring Today
Barchart
Stocks Under Pressure Ahead of Tuesday’s Election and FOMC Meeting
MarketBeat
MarketBeat Week in Review – 10/28 - 11/1
MarketBeat
Viking Therapeutics Stock: A Pre-Election Bet Worth Considering
Motley Fool
This High-Flying Stock Just Became a Better Buy
Barchart
Up 285% YTD, Is It Too Late to Buy This Biotech Stock?
Motley Fool
Could Buying This Weight Loss Stock Be Like Investing in Novo Nordisk At The Dawn of The GLP-1 Revolution?
Motley Fool
Why Viking Therapeutics Stock Soared by Nearly 21% on Thursday
Newswire.ca
Health and Wellness Industry Embraces Surge in Demand for Weight Loss Drugs
Motley Fool
3 Growth Stocks That Have Generated 1,000% Returns Since the Last Presidential Election (and They've All Outperformed Nvidia)
Stock Target Advisor
Viking Therapeutics Reports Strong Q3 Results with Promising Clinical Progress
Motley Fool
Viking Therapeutics Gives Investors Another Reason to Remain Bullish on Its Future
Motley Fool
Where Will Viking Therapeutics Be in 5 Years?

Profile

Viking Therapeutics, Inc. is a biopharmaceutical company. The company is engaged in development of novel therapies for metabolic and endocrine disorders. Its product candidate consists of VK5211, VK0214, VK0612 and VK2809 which are in different clinical trial. Viking Therapeutics, Inc. is based in LA JOLLA, United States.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2024.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).

Copyright © 2024 Morningstar. All Rights Reserved. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information. Past performance is no guarantee of future results.